Skip to main content
FinSpry Logo
FinSpry
ALNY logo
ALNY
(NASDAQ)
Alnylam Pharmaceuticals, Inc.
$268.74-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Alnylam Pharmaceuticals, Inc. (ALNY) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Alnylam Pharmaceuticals, Inc. stock.

Analyst Consensus Rating

Investment consensus from 29 professional research analysts

Consensus Rating

Buy
Based on 29 unique analysts
(47 total ratings in last 90 days)
Very High Confidence22.0:1 Buy/Sell

Average Price Target

$422.92
↑ 57.37% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest ALNY Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Paul Matteis
Stifel Nicolaus
BuyMaintains
$444.00
Tazeen Ahmad
BofA Securities
BuyReiterates
$460.00 → $410.00
Patrick Trucchio
HC Wainwright
BuyReiterates
$470.00 → $485.00
Danielle Brill
Truist
BuyMaintains
-
Eliana Merle
Barclays
BuyMaintains
$527.00
Michael Ulz
Morgan Stanley
HoldMaintains
$370.00 → $400.00
Jessica Fye
JP Morgan
BuyMaintains
-
Martin Auster
Raymond James
BuyReiterates
$468.00
Patrick Trucchio
HC Wainwright
BuyReiterates
$470.00
Ahan Chakraborty
Zacks Equity Research
SellInitiates Coverage
-
Whitney Ijem
Canaccord Genuity
BuyMaintains
$429.00
Michael Ulz
Morgan Stanley
HoldMaintains
$370.00
Eliana Merle
Barclays
BuyMaintains
$527.00
Tazeen Ahmad
BofA Securities
BuyMaintains
$460.00
Danielle Brill
Truist
BuyMaintains
-
Salveen Richter
Goldman Sachs
BuyMaintains
$550.00
Eric Joseph
Citi
BuyReiterates
-
Salveen Richter
Goldman Sachs
BuyMaintains
$550.00
Kostas Biliouris
Oppenheimer
BuyReiterates
$500.00
Joseph Stringer
Needham
BuyMaintains
$510.00
Luca Issi
RBC Capital
BuyMaintains
$445.00
Jessica Fye
JP Morgan
BuyReiterates
-
Patrick Trucchio
HC Wainwright
BuyReiterates
$510.00
Michael Ulz
Morgan Stanley
HoldMaintains
$370.00
Google Biotechnology
TipRanks - Google
BuyDowngrades
$337.00 → $333.00
PerPlexity Biotechnology
TipRanks - PerPlexity
BuyDowngrades
$323.00 → $333.00
Anthropic Biotechnology
TipRanks - Anthropic
HoldReiterates
$320.00 → $306.00
DeepSeek Biotechnology
TipRanks - DeepSeek
HoldReiterates
$336.00 → $324.00
xAi Biotechnology
TipRanks - xAI
HoldReiterates
$323.00 → $324.00
OpenAI Biotechnology
TipRanks - OpenAI
HoldReiterates
$330.00 → $322.00
Luca Issi
RBC Capital
BuyMaintains
$445.00
Unknown Analyst
JP Morgan
BuyMaintains
$420.00
Eric Joseph
Citi
BuyInitiates
$380.00
Eric Joseph
Citi
BuyInitiates
$380.00
Eliana Merle
Barclays
BuyMaintains
$527.00
Whitney Ijem
Canaccord Genuity
BuyMaintains
$429.00
Keay Nakae
Chardan Capital
BuyReiterates
$425.00
Edward Tenthoff
Piper Sandler
BuyReiterates
$489.00
Danielle Brill
Truist
BuyMaintains
-
William Pickering
Bernstein
BuyReiterates
$448.00 → $447.00
Kostas Biliouris
Oppenheimer
BuyReiterates
$500.00
Tiago Fauth
Raymond James
HoldMaintains
$376.00 → $377.00
Cory Kasimov
Evercore ISI Group
BuyReiterates
$400.00
Myles Minter
William Blair
BuyMaintains
-
Ritu Baral
TD Cowen
BuyMaintains
$482.00
Salveen Richter
Goldman Sachs
BuyMaintains
$549.00 → $550.00
Joseph Stringer
Needham
BuyMaintains
$510.00

Frequently Asked Questions

What is the analyst consensus rating for ALNY?

The analyst consensus rating for ALNY is "Buy" based on 29 analyst recommendations.

What is the average price target for ALNY?

The average 12-month price target for ALNY is $422.92, representing an upside of 57.4% from the current price of $268.74.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.